The FTC settlement with Caremark and Zinc Health targets pharmacy benefit managers to lower insulin costs and improve transparency for consumers.







Employers encourage weight loss medications like GLP-1 receptor agonists through direct-to-consumer platforms and health savings accounts for employees.

The FTC settlement with Caremark and Zinc Health targets pharmacy benefit managers to lower insulin costs and improve…

The U.S. Medicare drug pricing policy may cut costs by matching prices in other wealthy nations, reshaping pharmaceutical…

A new COVID-19 antibody treatment, VYD2311, enters phase 3 trials to evaluate safety and efficacy against mRNA vaccines.

Dermatologists propose ending routine blood tests for isotretinoin patients without risk factors to streamline acne treatment.

New PBM regulations in 2026 enhance transparency. Learn how industry changes impact healthcare practices.

Employers encourage weight loss medications like GLP-1 receptor agonists through direct-to-consumer platforms and health savings accounts for employees.

Managing chronic conditions can be overwhelming, chronic care management is key to connected care experience for millions of…

Discover how Neffy generated $72.2 million in sales within its first year, securing insurance coverage from major providers…

Updated trial data shows the ALK inhibitor lorlatinib achieves record progression-free survival for lung cancer, potentially changing treatment…

Physical inactivity is identified as the leading predictor of diabetes across U.S. counties, highlighting the urgent need for…